uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
August 01, 2024 07:05 ET
|
uniQure Inc.
~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data demonstrating the slowing of disease progression and reductions in a key biomarker of...
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
August 01, 2024 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
BigCommerce Announces Second Quarter 2024 Financial Results
August 01, 2024 07:05 ET
|
BigCommerce Holdings, Inc.
Second Quarter Total Revenue of $81.8 Million, an Increase of 8% Versus Prior Year. Total ARR of $345.8 Million, an Increase of 4% Versus Prior Year. Enterprise ARR of $253.8 Million, an Increase of...
Allegro MicroSystems Reports First Quarter 2025 Results
August 01, 2024 07:00 ET
|
Allegro MicroSystems, Inc.
– Sales of $167 Million Above Mid-point of Our Outlook –– Made $50 Million Voluntary Debt Repayment – – Announced Repurchase of 39 Million Shares From Majority Shareholder – MANCHESTER,...
Colliers Reports Solid Second Quarter Results
August 01, 2024 07:00 ET
|
Colliers International Group Inc
Growth across all service lines and segments Second quarter and year to date operating highlights: Three months ended Six months ended June 30 June 30(in millions of US$, except...
Sotera Health Appoints Christopher Simon to the Board of Directors
August 01, 2024 07:00 ET
|
Sotera Health Services, LLC
CLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory...
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
August 01, 2024 07:00 ET
|
ADMA Biologics, Inc.
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
Destination XL Group, Inc. to Announce Second Quarter 2024 Financial Results on August 29, 2024
August 01, 2024 07:00 ET
|
Destination XL Group, Inc.
CANTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, announced today it will...
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
August 01, 2024 07:00 ET
|
Passage Bio
Granted exclusive, worldwide rights for the development and commercialization of PBGM01 for GM1 gangliosidosis, PBKR03 for Krabbe disease, and PBML04 for metachromatic leukodystrophy to GEMMA...
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 01, 2024 07:00 ET
|
C4 Therapeutics, Inc.
Preliminary Monotherapy Data from the Ongoing CFT1946 Phase 1 Trial in BRAF V600X Solid Tumors to be Presented at ESMO Congress 2024; Initiated Monotherapy Expansion Cohort in Melanoma and Combination...